Treatment of antibody-mediated rejection including immunoadsorption during first year after renal transplantation--Clinical results and regulation of endothelial progenitor cells.

Abstract excerpt

OBJECTIVE: Antibody-mediated rejection (AMR) is associated with poor allograft survival. Therefore, effective treatment strategies are required. Extracorporeal strategies are increasingly included in treatment of antibody-mediated rejection to eliminate the detrimental alloantibodies. Yet, other...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to ABO Blood-Group System
• Share to Blood Component Removal
• Share to Endothelial Progenitor Cells